{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:16:37Z","timestamp":1791209797270,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.lpm.2015.03.002","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T21:02:56Z","timestamp":1429045376000},"page":"e121-e136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"P2","title":["Update on clinically isolated syndrome"],"prefix":"10.1016","volume":"44","author":[{"given":"\u00c9ric","family":"Thouvenot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2015.03.002_bib0005","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2015.03.002_bib0010","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awm329","article-title":"Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis","volume":"131","author":"Fisniku","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2015.03.002_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0025","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0035","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","article-title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","volume":"14","author":"Miller","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0040","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1191\/1352458503ms914oa","article-title":"Long-term follow-up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis","volume":"9","author":"Eriksson","year":"2003","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaut.2014.01.022","article-title":"The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review","volume":"48\u201349","author":"Karussis","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.lpm.2015.03.002_bib0050","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awn098","article-title":"Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis","volume":"131","author":"Lucchinetti","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2015.03.002_bib0055","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0060","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","article-title":"Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis","volume":"120","author":"Barkhof","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2015.03.002_bib0065","first-page":"702","article-title":"Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis","volume":"21","author":"Tintore","year":"2000","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1474-4422(07)70176-X","article-title":"MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study","volume":"6","author":"Swanton","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0075","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMcp053247","article-title":"Clinical practice. Optic neuritis","volume":"354","author":"Balcer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.03.002_bib0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0085","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0090","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000188896.48308.26","article-title":"Idiopathic acute transverse myelitis: application of the recent diagnostic criteria","volume":"65","author":"de Seze","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0095","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1212\/WNL.0b013e31821d750c","article-title":"Diabetes insipidus as a first manifestation in multiple sclerosis","volume":"76","author":"Thouvenot","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0100","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1352458510386999","article-title":"Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome","volume":"17","author":"Ruet","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0105","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/1352458509345906","article-title":"Clinically isolated acute transverse myelitis: prognostic features and incidence","volume":"15","author":"Young","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0110","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/1352458511426740","article-title":"The effect of gender in clinically isolated syndrome (CIS): a meta-analysis","volume":"18","author":"Dobson","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0115","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00415-009-5063-0","article-title":"Clinical predictors of early second event in patients with clinically isolated syndrome","volume":"256","author":"Mowry","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.21886","article-title":"Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis","volume":"67","author":"Lunemann","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1352458513494959","article-title":"Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes","volume":"20","author":"Martinelli","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0130","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1177\/1352458508093679","article-title":"Smoking is a risk factor for early conversion to clinically definite multiple sclerosis","volume":"14","author":"Di Pauli","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0135","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1177\/1352458506074178","article-title":"Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohort","volume":"13","author":"Pelayo","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0140","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0145","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00415-013-6838-x","article-title":"Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study","volume":"260","author":"D\u2019Alessandro","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0150","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archneur.57.7.974","article-title":"Multiple sclerosis-from probable to definite diagnosis: a 7-year prospective study","volume":"57","author":"Achiron","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1352458509350311","article-title":"Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes","volume":"16","author":"Zipoli","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0160","article-title":"Fatigue at time of CIS is an independent predictor of a subsequent diagnosis of multiple sclerosis","author":"Runia","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2015.03.002_bib0165","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.jocn.2014.02.026","article-title":"Clinically isolated syndromes and the relationship to multiple sclerosis","volume":"21","author":"Brownlee","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.lpm.2015.03.002_bib0170","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","article-title":"Clinically isolated syndromes","volume":"11","author":"Miller","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurad.2014.12.001","article-title":"OFSEP, a nationwide cohort of people with multiple sclerosis: consensus minimal MRI protocol","author":"Cotton","year":"2015","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0180","first-page":"455","article-title":"Standardized MR imaging protocol for multiple sclerosis: consortium of MS Centers consensus guidelines","volume":"27","author":"Simon","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0185","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ana.21606","article-title":"Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach","volume":"65","author":"Sormani","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1474-4422(06)70353-2","article-title":"MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study","volume":"5","author":"Korteweg","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0195","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/jnnp.2005.073247","article-title":"Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes","volume":"77","author":"Swanton","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2015.03.002_bib0200","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archneurol.2009.49","article-title":"A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis","volume":"66","author":"Rovira","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0205","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1212\/WNL.0b013e31827debeb","article-title":"Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis","volume":"80","author":"Giorgio","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0210","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1177\/1352458514526083","article-title":"Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes","volume":"20","author":"Mitjana","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0215","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00415-011-6345-x","article-title":"Assessing the value of spinal cord lesions in predicting development of multiple sclerosis in patients with clinically isolated syndromes","volume":"259","author":"Patrucco","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.0b013e31827b1a67","article-title":"Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis","volume":"80","author":"Sombekke","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0225","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.2009.171769","article-title":"Brain atrophy and lesion load measures over 1year relate to clinical status after 6years in patients with clinically isolated syndromes","volume":"81","author":"Di Filippo","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2015.03.002_bib0230","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nicl.2014.09.015","article-title":"MRI correlates of disability progression in patients with CIS over 48months","volume":"6","author":"Uher","year":"2014","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.lpm.2015.03.002_bib0235","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1177\/1352458513488231","article-title":"Clinical impact of early brain atrophy in clinically isolated syndromes","volume":"19","author":"Perez-Miralles","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0240","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1148\/radiol.13122424","article-title":"Thalamic atrophy is associated with development of clinically definite multiple sclerosis","volume":"268","author":"Zivadinov","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0245","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.0b013e318220abd4","article-title":"The predictive value of gray matter atrophy in clinically isolated syndromes","volume":"77","author":"Calabrese","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0250","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1474-4422(13)70233-3","article-title":"Body fluid biomarkers in multiple sclerosis","volume":"13","author":"Comabella","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0255","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","article-title":"Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness","volume":"180","author":"Link","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0260","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/135245850100700603","article-title":"Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS","volume":"7","author":"Tintore","year":"2001","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0265","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/jnnp-2012-304695","article-title":"Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude","volume":"84","author":"Dobson","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2015.03.002_bib0270","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/01.wnl.0000280576.73609.c6","article-title":"Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?","volume":"70","author":"Tintore","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0275","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.0b013e3181cec45c","article-title":"MRI criteria for MS in patients with clinically isolated syndromes","volume":"74","author":"Montalban","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0280","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jneuroim.2014.08.003","article-title":"High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis","volume":"276","author":"Hassan-Smith","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0285","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2013.01.011","article-title":"Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome","volume":"257","author":"Ferraro","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0290","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/1352458511424589","article-title":"Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual","volume":"18","author":"Durante","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0295","doi-asserted-by":"crossref","first-page":"e7638","DOI":"10.1371\/journal.pone.0007638","article-title":"IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome","volume":"4","author":"Brettschneider","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2015.03.002_bib0300","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/1352458510396922","article-title":"Increased peripheral blood CD5+ B-cells predict earlier conversion to MS in high-risk clinically isolated syndromes","volume":"17","author":"Villar","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0305","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/brain\/awq035","article-title":"Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis","volume":"133","author":"Comabella","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2015.03.002_bib0310","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1191\/1352458504ms1023oa","article-title":"Proteomic analysis of multiple sclerosis cerebrospinal fluid","volume":"10","author":"Hammack","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0315","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awv017","article-title":"Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes","author":"Canto","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2015.03.002_bib0320","doi-asserted-by":"crossref","DOI":"10.1177\/1352458514561906","article-title":"Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis","author":"Hinsinger","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0325","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12974-014-0181-8","article-title":"Validation of semaphorin 7A and ala-beta-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis","volume":"11","author":"Canto","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.lpm.2015.03.002_bib0330","doi-asserted-by":"crossref","first-page":"e48370","DOI":"10.1371\/journal.pone.0048370","article-title":"Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation","volume":"7","author":"Bielekova","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2015.03.002_bib0335","doi-asserted-by":"crossref","DOI":"10.1177\/1352458514564482","article-title":"Subclinical central inflammation is risk for RIS and CIS conversion to MS","author":"Rossi","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0340","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1352458510389102","article-title":"Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course","volume":"17","author":"Khademi","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0345","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/1352458513491166","article-title":"Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome","volume":"20","author":"Orbach","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0350","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1191\/135248506ms1263oa","article-title":"Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis","volume":"12","author":"Brettschneider","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0355","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1212\/WNL.0b013e31821432ff","article-title":"Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis","volume":"76","author":"Kuhle","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0360","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1093\/brain\/124.11.2162","article-title":"Visual and motor evoked potentials in the course of multiple sclerosis","volume":"124","author":"Fuhr","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2015.03.002_bib0365","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1191\/135248506ms1244oa","article-title":"Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis","volume":"12","author":"Kallmann","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0370","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/1352458507085061","article-title":"Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria","volume":"14","author":"Simo","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0375","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1352458509352666","article-title":"Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?","volume":"16","author":"Pelayo","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0380","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1167\/iovs.14-14807","article-title":"Evaluation of visual structural and functional factors that predict the development of multiple sclerosis in clinically isolated syndrome patients","volume":"55","author":"Perez-Rico","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.lpm.2015.03.002_bib0385","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archneurol.2009.265","article-title":"Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss","volume":"66","author":"Outteryck","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0390","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0395","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/ene.12617","article-title":"Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis","volume":"22","author":"Thouvenot","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0400","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaneurol.2013.5993","article-title":"Vitamin D as an early predictor of multiple sclerosis activity and progression","volume":"71","author":"Ascherio","year":"2014","journal-title":"JAMA neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0405","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.61.2.217","article-title":"Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis","volume":"61","author":"Minneboo","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0410","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/121.3.495","article-title":"The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up","volume":"121","author":"O\u2019Riordan","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2015.03.002_bib0415","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1352458511420269","article-title":"Brain lesion location and clinical status 20years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis","volume":"18","author":"Dalton","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0420","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00415-004-0349-8","article-title":"The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA","volume":"251","author":"Paolillo","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0425","doi-asserted-by":"crossref","DOI":"10.1177\/1352458514568827","article-title":"Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study","author":"Kuhle","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0430","doi-asserted-by":"crossref","DOI":"10.1177\/1352458515574148","article-title":"Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis","author":"Modvig","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0435","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1474-4422(11)70262-9","article-title":"Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial","volume":"11","author":"Comi","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0440","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2015.03.002_bib0445","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis","volume":"343","author":"Jacobs","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.03.002_bib0450","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000237641.33768.8d","article-title":"Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes","volume":"67","author":"Kappos","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0455","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(09)61259-9","article-title":"Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial","volume":"374","author":"Comi","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2015.03.002_bib0460","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1177\/1352458512469695","article-title":"Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome","volume":"19","author":"Comi","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0465","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(07)61194-5","article-title":"Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study","volume":"370","author":"Kappos","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2015.03.002_bib0470","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(09)70237-6","article-title":"Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial","volume":"8","author":"Kappos","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0475","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/01.wnl.0000200778.65597.ae","article-title":"IM interferon beta-1a delays definite multiple sclerosis 5years after a first demyelinating event","volume":"66","author":"Kinkel","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0480","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/jnnp-2013-306222","article-title":"Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT","volume":"85","author":"Edan","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2015.03.002_bib0485","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archneurol.2011.1426","volume":"69","author":"Kinkel","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0490","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S1474-4422(14)70191-7","article-title":"Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"13","author":"Miller","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0495","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1212\/WNL.0b013e31824f7fdd","article-title":"Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study","volume":"78","author":"Waubant","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2015.03.002_bib0500","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/1352458512474092","article-title":"If I had a clinically isolated syndrome with MRI diagnostic of MS, I would take vitamin D 10,000 IU daily: no","volume":"19","author":"Papeix","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0505","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s00415-010-5561-0","article-title":"Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis","volume":"257","author":"Rojas","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0510","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-0404.2010.01454.x","article-title":"Accuracy of diagnostic tests in multiple sclerosis \u2013 a systematic review","volume":"124","author":"Schaffler","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.lpm.2015.03.002_bib0515","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1177\/1352458514533397","article-title":"Early predictors of multiple sclerosis after a typical clinically isolated syndrome","volume":"20","author":"Ruet","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2015.03.002_bib0520","article-title":"The prognostic utility of mri in clinically isolated syndrome: a literature review","author":"Odenthal","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.lpm.2015.03.002_bib0525","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.nicl.2014.11.021","article-title":"Predicting outcome in clinically isolated syndrome using machine-learning","volume":"7","author":"Wottschel","year":"2015","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.lpm.2015.03.002_bib0530","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jns.2014.05.023","article-title":"Predictive markers of disease evolution after a CIS in everyday practice","volume":"343","author":"Arrambide","year":"2014","journal-title":"J Neurol Sci"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549821500127X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549821500127X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T10:01:06Z","timestamp":1537696866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075549821500127X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S075549821500127X"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2015.03.002","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on clinically isolated syndrome","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2015.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2015.02.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.10.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2015.02.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.10.019","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2015.01.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2015.02.011","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}